MicroGenDX

Unlock the power of Next-Generation Sequencing with MicroGenDX and never let cultures keep you down. Our innovative DNA sequencing analysis process can identify over 50,000 microbial species accurately and quickly to provide health professionals with all the information they need for confident treatment decisions. Explore this groundbreaking technology today! Click on our link https://loom.ly/BFCDCM8 to learn more about what we do!

Join us on December 4, 2024, at 2 pm ET for an free Dark Daily webinar sponsored by MicroGenDX! New Approach for Optimizing Antifungal Therapy: Two-Step Rapid Fungal Diagnostic by PCR/NGS Explore our groundbreaking 2-step PCR/NGS diagnostic tool that identifies fungal infections with unmatched precision in just 24-48 hours. Learn how this advanced technology enables rapid, accurate identification of molds and yeasts—helping healthcare providers optimize antifungal treatments and improve patient outcomes. -Explore an innovative 2-step PCR/NGS diagnostic tool designed for rapid and sensitive fungal diagnosis. -Analyze the prevalence of pathogenic yeasts and molds and their effects on current diagnostic practices. -Learn how this can save your hospital money on antifungal treatments Featuring Expert Speakers: Jose Alexander, MD (AdventHealth) Nicholas Sanford, PhD (MicroGenDX) Register Here: https://loom.ly/SabINZ8 #AntifungalTherapy #FungalInfections #PCRTesting #NextGenSequencing #MicroGenDX #HealthcareInnovation #InfectiousDiseases #DiagnosticTools #PatientOutcomes #LabDiagnostics #ClinicalMicrobiology #AntibioticStewardship #MedicalWebinar #DarkDaily

At MicroGenDX, we believe data holds the key to innovation. On this #WorldStatisticsDay, we're excited to showcase a key finding from a paper authored by a scientist on our staff: a network map illustrating the complex relationships between wound microbiome species and how patient genetics could tip the scale towards certain types of infection. 🔍 Tipton et al. 2020 revealed that genetic variations in patients significantly influence wound microbiome diversity and infection types. Here, a single mutation was found to be associated with the abundance of two very common bacteria often found in chronic wounds, Staphylococcus epidermidis (#12) or Pseudomonas aeruginosa (#10) in the graph below (Fig. 2). The network plot highlights the different ways that these two selected species interacted with other microbial species, with black lines showing positive associations and orange lines showing negative ones. Staphylococcus epidermidis is sometimes thought to be less harmful or even potentially beneficial in the context of an open wound. The strong negative correlations observed between S. epidermidis and known pathogens like S. aureus and Pseudomonas seem to back up the idea that S. epidermidis may have a beneficial role in preventing colonization by worse pathogens. These data help explain why some wounds struggle to heal and why some patients may seem prone to frequent re-infection by the same organism! This visualization is a powerful reminder that statistics aren’t just numbers – they drive discovery and lead to more personalized treatment options for chronic wounds. 📉 Read more of our research here: https://loom.ly/XGe1i_k #DataScience #Microbiome #PersonalizedMedicine #MedicalResearch #WoundHealing #StatisticsInHealthcare #MicroGenDX #Statistics

We’re thrilled to share that Lori Johnson, NP, along with Dr. Drue Orwig and Craig Tipton (of MicroGenDX), has completed groundbreaking research showcasing the power of Next-Generation DNA Sequencing (NGS) in guiding targeted antimicrobial therapies for chronic, non-healing wounds. Their study reveals how NGS can pinpoint precise microbial profiles, leading to dramatic wound healing in patients where traditional treatments had failed. For those heading to the SAWC Fall Conference in Las Vegas, stop by the poster area on Friday, October 4th at 6:15-7:30pm to see Lori Johnson’s poster presentation. #SAWC2024 #WoundCare #NGSResearch #MicroGenDX #TopicalAntimicrobial #ChronicWounds #SAWC #NGS #WoundHealing #Research

I have got plans for this one! More to come on this case in the next months. 42 yo male S/P “train wreck”. ICM score 6 with +NGS per Microgen DX (8 organisms). Culture negative. B Host. Will have to bring everything to bear to make this a success. 🙏🏼 #ThanksMicrogenDX #OxfordPerformanceMaterials #3DSide #LINKHingeinaBox

Staphylococcus lugdunensis + w/ open biopsy per next generation sequencing via Microgen DX. Negative cultures from the open biopsy. Now that we have identified the problem, now to work...

Urine Pathogenicity Now Available on All Reports As of September 1st, 2024 MicroGenDX will now be offering a pathogenicity rating on all qPCR+NGS urine samples. This rates all organisms found in that report as: [P] = Known Pathogen [C] = Commensal / Unlikely Pathogen [U] = Unknown This column is found to the right of the NGS% column .  These ratings are based on an in-house developed AI algorithm. Please note that these ratings are for healthcare provider reference only and assume the patient is not immunocompromised. The final treatment decisions rest at the physician's discretion, and all patient health factors should be taken into account. This report is currently only available for Urine Samples.  To order please visit: https://loom.ly/a44XP7o #MicroGenDX #PathogenTesting #InfectiousDisease #NextGenSequencing #LabTesting #UrineAnalysis #HealthcareAI #MedicalAdvancements #ClinicalDiagnostics #PatientCare #HealthcareProviders #Urology #Urine

NGS has uncovered what conventional culture overlooked; many cases of nonunion may be the result of a polymicrobial invasion that had previously gone undetected. Take a look at this study here: https://loom.ly/fjt6PfQ

Exciting Discovery: How NGS Diagnosed Whipple’s Disease when other tests failed! Discover the power of Next Generation DNA Sequencing (NGS) in uncovering rare infections like Whipple’s Disease! Our latest case study showcases the clinical utility offered by MicroGenDX's NGS testing, revealing Tropheryma whipplei when traditional tests failed. https://loom.ly/jXU0F8Q 🔍 Patient's journey: An African-American female in her early 40’s saw her primary care physician after suffering from several weeks of worsening dyspnea with cough and arthralgias. The patient underwent a bronchoscopy with bronchoalveolar lavage (BAL) and lung biopsy. The artifacts from these operations were subjected to a litany of medical tests, including: -Bronchoscopy with bronchoalveolar lavage (BAL) -BAL bacterial cultures -BAL acid-fast bacilli cultures -BAL fungal cultures -Aspergillus galactomannan of the BAL -BAL cytology for malignancy -BAL Pneumocystis jirovecii polymerase chain reaction (PCR) -Hypersensitivity pneumonitis panel -BAL pneumonia PCR panel -Lung biopsy Periodic acid-Schiff (PAS) stain However, a MicroGenDX NGS test detected the presence of Tropheryma whipplei in the BAL sample. Furthermore, an EGD revealed chronically active Heliobacter gastritis and normal duodenal specimens with no evidence of T. whipplei. No MicroGenDX testing was used in the GI tract. Ready to experience the leading-edge in infectious disease testing? Order your MicroGenDX test today! https://loom.ly/qf6fuUU #NGS #medicalinnovation #futureofmedicine #healthcare

We’re excited to offer you more flexible payment options at https://loom.ly/9iyIZE0 with our new “Pay Over Time” plans! You can now spread the cost of your medical services using: -Klarna -Affirm -AfterPay Your health and well-being are our top priorities, and now you can manage your payments in a way that suits your budget. Visit our website today to learn more about these convenient payment plans and continue receiving the top-notch medical services you trust. #MicroGenDX #MedicalInnovation #FlexiblePayments #Klarna #Affirm #AfterPay #Healthcare